ConscienHealth

Ted Kyle and ConscienHealth work with experts to advance sound approaches to health and obesity, the biggest threat to America's health for this century.

ConscienHealth works with experts and organizations to advance sound approaches to health and obesity, the biggest threat to the health of America in this century. We advocate for evidence-based prevention and treatment. We help organizations develop strategies to advance new options from research to adoption in clinical practice and health policy. We develop strategies that are based on sound sci

ence, public policy, and a deep understanding of consumer needs. We help experts and advocates to educate the public and provide a voice for people affected by obesity.

08/19/2025

Can we imagine a $5,000 penalty for relapsing breast cancer? Of course not. But after obesity surgery, a school district feels OK about a $5,000 penalty for weight regain.

Nope, is not gone. It's just sneakier.
https://conscienhealth.org/2025/08/bias-ever-present-a-5000-penalty-for-obesity-relapse/

08/18/2025

A new editorial in The New England Journal of Medicine has us thinking that analysts who dismiss outcomes with and are missing a big shift in goals for obesity treatment. Long-term health is becoming more important than short-term weight loss alone.
https://conscienhealth.org/2025/08/targeting-better-health-with-new-obesity-drugs/

08/17/2025

Yet another study suggests that exposure influences weight regain after treatment. Overlooking the harm of endocrine disrupting chemicals is a mistake.
https://conscienhealth.org/2025/08/pfas-exposure-predicts-weight-gain-after-metabolic-surgery/

08/16/2025

Yesterday, became the first with an indication for . This is a big deal because it supports the understanding that treating obesity is all about long-term gains in health, not just short-term weight loss.
https://conscienhealth.org/2025/08/wegovy-gets-the-ok-from-fda-for-a-mash-indication/

08/15/2025

President Trump said he wanted drug prices to go up in the rest of the world and come down in the U.S. Eli Lilly and Company got the first part of that message and dutifully hiked the in the UK to nearly triple its old price.
https://conscienhealth.org/2025/08/trump-prompts-a-huge-mounjaro-price-hike-in-the-uk/

08/14/2025

An impressive analysis of a in tells us that walkable cities really do nudge people to get more active. This is good news.
HT: Nature
https://conscienhealth.org/2025/08/yes-walkable-cities-lead-people-to-walk-more/

08/13/2025

It looks like AHA got the jump on MAHA and issued a scientific advisory on ahead of the alternative science coming from RFK's commission.
HT: American Heart Association
https://conscienhealth.org/2025/08/american-heart-jumps-ahead-of-maha-on-ultra-processed-foods/

08/12/2025

Yesterday, Obesity Canada - Obésité Canada took another leap forward with their second update to clinical guidance for . In the background lurks some unresolved dissonance in clinical definitions for .
https://conscienhealth.org/2025/08/canadian-clinical-guidance-for-obesity-medicines-leaps-ahead/

08/11/2025

Here's something to ponder. Floating in the North Atlantic, there are more metric tons of than the combined mass of all mammals living on dry land. As a reservoir for , can we ignore them?
https://conscienhealth.org/2025/08/27-million-metric-tons-of-nanoplastic-in-the-north-atlantic/

08/10/2025

“I was trying to tell people for years that five to ten percent weight loss has important benefits – and it really does. But patients simply were not buying it.”

Now we have the tools and struggle is to deliver obesity care at scale to those who need it.
https://conscienhealth.org/2025/08/moving-obesity-medicine-from-sisyphus-to-the-snowball/

08/09/2025

For a while, potato punditry held that the problem was potatoes. The Harvard nutrition gurus have gotten over it. Now they say it's the frying that makes them bad. No, no, no, says our HHS Sec. It's the seed oils, dummies. Mixed messages make heads spin.
https://conscienhealth.org/2025/08/is-it-the-seed-oil-the-fries-or-not-so-simple-as-hubris-suggests/

08/08/2025

Yesterday Eli Lilly and Company announced topline results for phase 3 orforglipron studies – 12% weight loss at 72 weeks. Investors were unimpressed. They are more focused on short-term weight loss than long-term care and outcomes. They're not alone in this.
https://conscienhealth.org/2025/08/learning-obesity-treatment-is-a-marathon-not-a-sprint/

Address

Pittsburgh, PA
15241

Telephone

+1.412.206.9303

Website

http://www.conscienhealth.org/news

Alerts

Be the first to know and let us send you an email when ConscienHealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ConscienHealth:

Shortcuts

Want your practice to be the top-listed Clinic in Pittsburgh?